4
Changes in Ownership
NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001709738-25-000005
Business Development Director sold 11,019 shares at an average $0.66 ($7,306)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Christianson Mark Business Development Director | 2025-05-19 | Sale | −8,006 | $0.67 | $5,330 | 283,485 | D: show line 1 in the form |
| Christianson Mark Business Development Director | 2025-05-20 | Sale | −3,013 | $0.66 | $1,976 | 280,472 | D: show line 2 in the form |
| Open-market sales · 11,019 sh · avg $0.66 · $7,306 | |||||||
Loading xslF345X05/primary_doc.xml…